Simultaneous determination of antidementia drugs in human plasma: Procedure transfer from HPLC-MS to UPLC-MS/MS

Journal of Pharmaceutical and Biomedical Analysis

Volumn 64-65, Issue , 2012, Pages 16-25

  Noetzli, Muriel ^a   Ansermot, Nicolas ^a   Dobrinas, Maria ^a   Eap, Chin B ^a,b  

^a Hopital de Cery   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Donepezil; Galantamine; Memantine; Rivastigmine; UPLC MS MS

Indexed keywords

ACETONITRILE; AMMONIUM ACETATE; DONEPEZIL; DRUG METABOLITE; GALANTAMINE; MEMANTINE; NAP 226 90; RIVASTIGMINE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; DRUG BLOOD LEVEL; DRUG MONITORING; DRUG STRUCTURE; ELECTROSPRAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTERMETHOD COMPARISON; MASS SPECTROMETRY; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; GALANTAMINE; HUMANS; INDANS; MEMANTINE; NOOTROPIC AGENTS; PHENETHYLAMINES; PHENOLS; PHENYLCARBAMATES; PIPERIDINES; PLASMA; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY;

EID: 84859267316     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2012.02.008     Document Type: Article

References (40)

1. Hiemke C., Baumann P., Bergemann N., Conca A., Dietmaier O., Egberts K., Fric M., Gerlach M., Greiner C., Grunder G., Haen E., Havemann-Reinecke U., Jaquenoud Sirot E., Kirchherr H., Laux G., Lutz U.C., Messer T., Muller M.J., Pfuhlmann B., Rambeck B., Riederer P., Schoppek B., Stingl J., Uhr M., Ulrich S., Waschgler R., Zernig G. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. Pharmacopsychiatry 2011, 44:195-235.
2. Touw D.J., Neef C., Thomson A.H., Vinks A.A. Cost-effectiveness of therapeutic drug monitoring - a systematic review. Ther. Drug Monit. 2005, 27:10-17.
3. Lanctot K.L., Herrmann N., Yau K.K., Khan L.R., Liu B.A., LouLou M.M., Einarson T.R. Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis. CMAJ 2003, 169:557-564.
4. Reisberg B., Doody R., Stoffler A., Schmitt F., Ferris S., Mobius H.J. Memantine in moderate-to-severe Alzheimer's disease. N. Engl. J. Med. 2003, 348:1333-1341.
5. Rockwood K., MacKnight C. Assessing the clinical importance of statistically significant improvement in anti-dementia drug trials. Neuroepidemiology 2001, 20:51-56.
6. Varsaldi F., Miglio G., Scordo M.G., Dahl M.L., Villa L.M., Biolcati A., Lombardi G. Impact of the CYP2D6 polymorphism on steady-state plasma concentrations and clinical outcome of donepezil in Alzheimer's disease patients. Eur. J. Clin. Pharmacol. 2006, 62:721-726.
7. Spencer C.M., Noble S., Rivastigmine A review of its use in Alzheimer's disease. Drugs Aging 1998, 13:391-411.
8. Kornhuber J., Kennepohl E.M., Bleich S., Wiltfang J., Kraus T., Reulbach U., Meineke I. Memantine pharmacotherapy: a naturalistic study using a population pharmacokinetic approach. Clin. Pharmacokinet. 2007, 46:599-612.
9. Arlt S., Lindner R., Rosler A., von Renteln-Kruse W. Adherence to medication in patients with dementia: predictors and strategies for improvement. Drugs Aging 2008, 25:1033-1047.
10. Noetzli M., Choong E., Ansermot N., Eap C.B. Simultaneous determination of antidementia drugs in human plasma for therapeutic drug monitoring. Ther. Drug Monit. 2011, 33:227-238.
11. Shah H.J., Kundlik M.L., Pandya A., Prajapati S., Subbaiah G., Patel C.N., Patel D.M., Suhagiya B.N. A rapid and specific approach for direct measurement of donepezil concentration in human plasma by LC-MS/MS employing solid-phase extraction. Biomed. Chromatogr. 2008, 23:141-151.
12. Patel B.N., Sharma N., Sanyal M., Shrivastav P.S. Quantitation of donepezil and its active metabolite 6-O-desmethyl donepezil in human plasma by a selective and sensitive liquid chromatography-tandem mass spectrometric method. Anal. Chim. Acta 2008, 629:145-157.
13. Frankfort S.V., Ouwehand M., van Maanen M.J., Rosing H., Tulner L.R., Beijnen J.H. A simple and sensitive assay for the quantitative analysis of rivastigmine and its metabolite NAP 226-90 in human EDTA plasma using coupled liquid chromatography and tandem mass spectrometry. Rapid Commun. Mass. Spectrom. 2006, 20:3330-3336.
14. Bhatt J., Subbaiah G., Kambli S., Shah B., Nigam S., Patel M., Saxena A., Baliga A., Parekh H., Yadav G. A rapid and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the estimation of rivastigmine in human plasma. J. Chromatogr. B 2007, 852:115-121.
15. Verhaeghe T., Diels L., De Vries R., De Meulder M., De Jong J. Development and validation of a liquid chromatographic-tandem mass spectrometric method for the determination of galantamine in human heparinised plasma. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2003, 789:337-346.
16. Nirogi R.V., Kandikere V.N., Mudigonda K., Maurya S. Quantitative determination of galantamine in human plasma by sensitive liquid chromatography-tandem mass spectrometry using loratadine as an internal standard. J. Chromatogr. Sci. 2007, 45:97-103.
17. Almeida A.A., Campos D.R., Bernasconi G., Calafatti S., Barros F.A., Eberlin M.N., Meurer E.C., Paris E.G., Pedrazzoli J. Determination of memantine in human plasma by liquid chromatography-electrospray tandem mass spectrometry: application to a bioequivalence study. J. Chromatogr. B 2007, 848:311-316.
18. Xie Z., Liao Q., Xu X., Yao M., Wan J., Liu D. Rapid and sensitive determination of donepezil in human plasma by liquid chromatography/tandem mass spectrometry: application to a pharmacokinetic study. Rapid Commun. Mass Spectrom. 2006, 20:3193-3198.
19. Pommier F., Frigola R. Quantitative determination of rivastigmine and its major metabolite in human plasma by liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry. J. Chromatogr. B 2003, 784:301-313.
20. Apostolou C., Dotsikas Y., Kousoulos C., Loukas Y.L. Quantitative determination of donepezil in human plasma by liquid chromatography/tandem mass spectrometry employing an automated liquid-liquid extraction based on 96-well format plates. Application to a bioequivalence study. J. Chromatogr. B 2007, 848:239-244.
21. Liu M.Y., Meng S.N., Wu H.Z., Wang S., Wei M.J. Pharmacokinetics of single-dose and multiple-dose memantine in healthy Chinese volunteers using an analytic method of liquid chromatography-tandem mass spectrometry. Clin. Ther. 2008, 30:641-653.
22. Chambers E., Wagrowski-Diehl D.M., Lu Z., Mazzeo J.R. Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses. J. Chromatogr. B 2007, 852:22-34.
23. University of Geneva, 2009, (last accessed January 2012). http://www.unige.ch/sciences/pharm/fanal/lcap/telechargement.htm.
24. Hubert P., Nguyen-Huu J.J., Boulanger B., Chapuizet E., Chiap P., Cohen N., Compagnon P.A., Dewe W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., Valat L. Validation of quantitative analytical procedure. Harmonization of approaches. STP Pharma Pract. 2003, 13:101-138.
25. FDA, 2001, (last accessed January 2012). http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdf.
26. EMEA, 2011, (last accessed January 2012). http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf.
27. Bonfiglio R., King R.C., Olah T.V., Merkle K. The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds. Rapid Commun. Mass Spectrom. 1999, 13:1175-1185.
28. Souverain S., Rudaz S., Veuthey J.L. Matrix effect in LC-ESI-MS and LC-APCI-MS with off-line and on-line extraction procedures. J. Chromatogr. A 2004, 1058:61-66.
29. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 2003, 75:3019-3030.
30. Farlow M.R. Clinical pharmacokinetics of galantamine. Clin. Pharmacokinet. 2003, 42:1383-1392.
31. Rogers S.L., Cooper N.M., Sukovaty R., Pederson J.E., Lee J.N., Friedhoff L.T. Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral doses. Br. J. Clin. Pharmacol. 1998, 46(Suppl. 1):7-12.
32. Lefevre G., Sedek G., Jhee S.S., Leibowitz M.T., Huang H.L., Enz A., Maton S., Ereshefsky L., Pommier F., Schmidli H., Appel-Dingemanse S. Pharmacokinetics and pharmacodynamics of the novel daily rivastigmine transdermal patch compared with twice-daily capsules in Alzheimer's disease patients. Clin. Pharmacol. Ther. 2008, 83:106-114.
33. Rozet E., Ceccato A., Hubert C., Ziemons E., Oprean R., Rudaz S., Boulanger B., Hubert P. Analysis of recent pharmaceutical regulatory documents on analytical method validation. J. Chromatogr. A 2007, 1158:111-125.
34. Rozet E., Hubert C., Ceccato A., Dewe W., Ziemons E., Moonen F., Michail K., Wintersteiger R., Streel B., Boulanger B., Hubert P. Using tolerance intervals in pre-study validation of analytical methods to predict in-study results. The fit-for-future-purpose concept. J. Chromatogr. A 2007, 1158:126-137.
35. Chen J., Hsieh Y. Stabilizing drug molecules in biological samples. Ther. Drug Monit. 2005, 27:617-624.
36. Passing H., Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I. J. Clin. Chem. Clin. Biochem. 1983, 21:709-720.
37. Passing H., Bablok W. Comparison of several regression procedures for method comparison studies and determination of sample sizes. Application of linear regression procedures for method comparison studies in Clinical Chemistry, Part II. J. Clin. Chem. Clin. Biochem. 1984, 22:431-445.
38. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 307-312.
39. Bergeron A., Furtado M., Garofolo F. Importance of using highly pure internal standards for successful liquid chromatography/tandem mass spectrometric bioanalytical assays. Rapid Commun. Mass Spectrom. 2009, 23:1287-1297.
40. Wieling J. LC-MS-MS experiences with internal standards. Chromatogr. Suppl. 2002, 55. S-107-S-113.